ask="3.85"
ask_size="200"
average_daily_volume="25305"
bid="3.63"
bid_size="200"
book_value="-0.23"
change="+0.68"
change_from_200_day_moving_average="0.11"
change_from_50_day_moving_average="1.09"
change_from_52_week_high="-1.75"
change_From_52_week_low="1.94"
change_in_percent="+22.22%"
close="3.74"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.67"
ebitda="-49.36M"
eps_estimate_current_year="-2.25"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.50"
ex_dividend_date="N/A"
float_shares="12319000"
high="3.95"
high_52_weeks="5.49"
last_trade_date="1/27/2017"
last_trade_price="3.74"
last_trade_size="102"
last_trade_time="4:00pm"
low="2.98"
low_52_weeks="1.80"
market_capitalization="88.18M"
moving_average_200_day="3.63"
moving_average_50_day="2.65"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="3.04"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.98%"
percent_change_from_50_day_moving_average="+41.23%"
percent_change_from_52_week_high="-31.88%"
percent_change_from_52_week_low="+107.33%"
previous_close="3.06"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="24.21"
revenue="2.98M"
shares_outstanding="23578000"
short_ratio="0.19"
stock_exchange="NGM"
symbol="ONS"
volume="384814"
weeks_range_52="1.80 - 5.49"
